Researchers from the Massachusetts Institute of Technology (MIT) and the California Institute of Technology (Caltech) have made significant strides in vaccine development that could protect against ...

Two-thirds of people with post-COVID-19 syndrome have persistent, objective symptoms – including reduced physical exercise capacity and reduced cognitive test performances – for a year or more, with ...

MIT and Caltech scientists designed a new vaccine targeting stable virus regions to protect against various coronavirus strains.

A new experimental vaccine developed by researchers at MIT and Caltech could offer protection against emerging variants of SARS-CoV-2, as well as related coronaviruses, known as sarbecoviruses, that ...

In the COVID-19 pandemic era, at-home, portable tests were crucial for knowing when to wear a mask or isolate at home. Now, ...

Investigators from Mass General Brigham​ have found that a method originally designed for cancer detection can also identify and monitor even tiny amounts of SARS-CoV-2 intact viral particles in blood ...

CDC testing data for the same period reveals that 6.6 percent of COVID-19 tests came back positive, with Illinois, Indiana, Michigan, Minnesota, Ohio and Wisconsin seeing the highest test positivity ...

In their Article, the HDR UK COALESCE Consortium concluded that those who are fully vaccinated against SARS-CoV-2 are less likely to be admitted to hospital and to die with COVID-19.1 If the tests for ...

Historically, COVID-19 symptoms have been fevers or chills, cough, shortness of breath, cough, congestion or a runny nose, ...

Nearly one in 20 people who had a SARS-CoV-2 infection go on to experience myalgic encephalomyelitis/chronic fatigue syndrome ...

New in vitro neutralization data show continued, consistent neutralizing activity of PEMGARDA™ (pemivibart) against XEC Centers for Disease ...

The following is a summary of “Multiplex lateral flow test sensitivity and specificity in detecting influenza A, B and ...